Cargando…
Optimal dose of etanercept in the treatment of rheumatoid arthritis
Etanercept (ETN) is one of a number of biological therapies targeting the proinflammatory cytokine tumor necrosis factor-alpha that have demonstrated efficacy in the management of rheumatoid arthritis (RA). As experience has grown, a number of different treatment strategies have been investigated to...
Autores principales: | Curtis, Elizabeth Mary, Marks, Jonathan Lewis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045112/ https://www.ncbi.nlm.nih.gov/pubmed/27790032 http://dx.doi.org/10.2147/OARRR.S41409 |
Ejemplares similares
-
Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007) -
Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016) -
Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000) -
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011) -
A Pilot Dose‐Finding Study of Etanercept in Rheumatoid Arthritis
por: Breedveld, Ferdinand C., et al.
Publicado: (2017)